María
Díez Campelo
Profesora Asociada CC. Salud
![Foto de María](/img/uploaded/38c5a6a747cb7a6f7166f9e46294ab84.jpg)
![Foto de Assistance Publique -Hopitaux De Paris](/img/noimage_org.png)
Assistance Publique -Hopitaux De Paris
París, FranciaPublicaciones en colaboración con investigadores/as de Assistance Publique -Hopitaux De Paris (7)
2024
-
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 24, pp. 2873-2886
-
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation
JCO clinical cancer informatics, Vol. 8, pp. e2300205
-
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study
Leukemia
2023
-
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 15, pp. 2827-2842
2020
2018
-
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries
British Journal of Haematology, Vol. 181, Núm. 3, pp. 350-359